Q-omics provides the consensus-scored MIR370 profile across patient tissues and cancer cell-line models. MIR370 expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in KICH. Among the 18 cancer types available for tumor–normal comparison, MIR370 is differentially expressed in 1, with the highest sampling consensus in LUAD. Additionally, MIR370 RNA expression shows 10,738 significant gene co-expression associations, with the highest sampling consensus in PCPG. Together, these results highlight KICH, LUAD, and PCPG as cancer lineages where MIR370 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR370 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR370 survival associations across molecular data types. MIR370 RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR370 RNA expression–survival associations across cancer types. High MIR370 expression shows unfavorable associations in KICH, READ, HNSC and THYM, but favorable associations in UCS and LAML. The KICH Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify KICH as the clearest survival context for MIR370 RNA expression.
This table summarizes MIR370 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in LUAD for RNA.
This table ranks reproducible tumor–normal expression differences for MIR370. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR370 shows higher tumor expression in LUAD. The LUAD box plot shows higher MIR370 RNA expression in tumor versus normal tissue (log2 FC = +0.095, t-test p = .037).
This table shows molecular features associated with MIR370 in patient tissues and cancer cell lines. In patient samples, MIR370 shows the broadest associations at the RNA and protein expression levels, with PCPG recurring as the lineage with the largest associated feature set.
